Aicher HD
Neuroscience Center Zurich, University of Zurich and ETH Zurich, Switzerland.
ArticlePsychedelics
Salvinorin A in humans: A systematic review of pharmacokinetics, pharmacodynamics, and safety.
ArticleDMT
Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.
ArticlePsilocybin
Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomized [<sup>18</sup>F]FDG-PET study.
ArticlePsilocybin
Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study.
ArticlePsilocybin
Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.
ArticlePsychedelics
Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes.
ArticlePsychedelics
Safety and efficacy are hardly separable in psychedelic therapy: A mechanism-based critique.
ArticlePsychedelics
The Role and Ethics of Touch and Non-touch in Psychedelic-Assisted Therapy.
ArticleAyahuasca
Ayahuasca-inspired DMT/harmine formulation alters creative thinking dynamics during artistic creation.
ArticlePsilocybin
Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.
ArticleAyahuasca
Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects.
ArticleAyahuasca
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces.
ArticlePsilocybin
Further education in psychedelic-assisted therapy - experiences from Switzerland.
ArticleAyahuasca
Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study.
ArticleAyahuasca
Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial.
ArticleAyahuasca
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors
PreprintAyahuasca
Ayahuasca-Inspired DMT/HAR Formulation Reduces Brain Differentiation Between Self and Other Faces
ArticleDMT
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.
ArticleAyahuasca
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.
ArticleAyahuasca
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.
ArticleAyahuasca